May 11, 2018 at AACR

Eradicating H. Pylori Reduces Gastric Cancer Risk


Eliminating Helicobacter pylori in patients with early gastric cancer may reduce the risk of recurring disease. In a recent study from American Association for Cancer Research, eradicating the bacterial infection reduced the risk of developing a subsequent gastric cancer by almost 50%. 

Read More
May 09, 2018 at Cancer Network

Managing Nausea and Vomiting in Patients With Cancer: What Works

By : Cancer Network

Recent research shows olanzapine may be an effective agent for the preventing and treating of chemo-induced nausea.

Read More
May 07, 2018 at The Lancet

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

By : The Lancet

A new study in The Lancet explores why postoperative chemoradiotherapy does not provide a survival benefit over chemotherapy  Researchers explain preoperative treatment strategies may provide more benefit to patients who have resectable gastric cancer. 

Read More
May 03, 2018 at A*Star

Artificial intelligence helps to pinpoint roots of gastric cancer

By : A*Star

Scientists in Singapore have developed a new computer model using machine learning and artificial intelligence to pinpoint gastric cancer mutations. Researchers have already identified new mutations in DNA that may cause gastric cancer.

Read More
May 02, 2018 at MD Linx

Body mass index and mortality in patients with gastric cancer: A large cohort study

By : MD Linx

A long-term study analyzed the relationship between body mass index (BMI) and gastric cancer patients undergoing surgery, and found underweight patients faced generally worse outcomes. 

Read More